[1]
Blomqvist, C. et al. 1992. FEC (5-Fluorouracil-Epirubicin-Cyclophosphamide) Monthly Versus FEC Weekly in Metastatic Breast Cancer: First results of a randomized trial. Acta Oncologica. 31, 2 (Jan. 1992), 231–236. DOI:https://doi.org/10.3109/02841869209088908.